跳至主要内容
临床试验/NCT06992297
NCT06992297已完成不适用

Clinical Evaluation of Long-term Sequelae in Patients With Severe Plasmodium Falciparum Malaria

Assistance Publique Hopitaux De Marseille1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2025年6月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
56
试验地点
1
主要终点
frequency of long-term sequelae of severe malaria

研究概览

简要总结

Malaria, endemic in 85 countries, remains a major concern. By 2022, there will be 249 million cases and 608,000 deaths, 94% of them in Africa. In France, 4995 cases of imported malaria were reported in 2021, with 15% of severe forms and a fatality rate of 2.5%. Long-term sequelae, such as kidney failure and neurological disorders, are well documented in children, but few studies have focused on adults.

the main objective is to describe and estimate the frequency of long-term sequelae of severe imported malaria treated at our centre.

the aim is to compare long-term neurological sequelae between neuromalaria and severe malaria without neurological disorders. In addition, the investigator aim to identify the clinical, radiological and biological factors associated with sequelae in order to improve post-hospitalisation follow-up. Finally, the investigator aim to describe acute complications arising at diagnosis and during hospitalisation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male or female over 18 years of age
  • •Have been diagnosed with severe malaria according to WHO criteria and have been treated between 1/1/2018 and 321/12/2024 at the AP-HM
  • •Have been treated with Artesunate IV (MALACEF®) (at least one dose)
  • •Patient who has received information about the study and has not expressed opposition
  • •Patient benefiting or entitled to benefit from a social security scheme

排除标准

  • •Patients with advanced neurodegenerative pathology pre-existing the malaria attack
  • •Subjects covered by articles L1121-5 to 1121-8 of the Public Health Code (minor patients, patients of legal age under guardianship, curatorship or safeguard of justice, patients deprived of their liberty, pregnant or breast-feeding women),
  • •Persons who do not understand French

研究组 & 干预措施

malaria patient

Other

干预措施: Questionnaire (Other)

结局指标

主要结局

frequency of long-term sequelae of severe malaria

时间窗: 12 months

Assessment of after-effects one year after diagnosis

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验